Found 10133 bookmarks
Newest
Does Prophylaxis Prevent Recurrent Clostridioides difficile Infection? - PubMed
Does Prophylaxis Prevent Recurrent Clostridioides difficile Infection? - PubMed
Prophylaxis and Recurrent Clostridioides difficileA 68-year-old woman is admitted with pyelonephritis. Two months earlier, she had been treated for pneumonia and subsequently developed Clostridioides difficile colitis, which resolved with 10 days of oral vancomycin. When you start trea …
·pubmed.ncbi.nlm.nih.gov·
Does Prophylaxis Prevent Recurrent Clostridioides difficile Infection? - PubMed
Change in Provider Specialty Was Associated With Less Fluoroquinolone Use at a Veterans Affairs Long-Term Care Setting - PubMed
Change in Provider Specialty Was Associated With Less Fluoroquinolone Use at a Veterans Affairs Long-Term Care Setting - PubMed
The comparable antibiotic use metrics before and after the general medical service assumed care of the CLC residents may be explained by constancy in resident population and other facility-related factors. Differences in the types of agents used suggests that antibiotic stewardship efforts can be ta …
·pubmed.ncbi.nlm.nih.gov·
Change in Provider Specialty Was Associated With Less Fluoroquinolone Use at a Veterans Affairs Long-Term Care Setting - PubMed
Atypical Clostridium difficile Infection in a Pregnant Patient: A Case Study on Non-Diarrheal Presentation and Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Complication
Atypical Clostridium difficile Infection in a Pregnant Patient: A Case Study on Non-Diarrheal Presentation and Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Complication
Clostridium difficile (C. difficile) is a Gram-positive, spore-producing bacterium that often leads to pseudomembranous colitis, typically manifesting as watery diarrhea. The risk factors for C....
·cureus.com·
Atypical Clostridium difficile Infection in a Pregnant Patient: A Case Study on Non-Diarrheal Presentation and Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Complication
The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients - PubMed
The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients - PubMed
Immune checkpoint inhibitors (ICI) are widely utilized for the treatment of malignant melanoma. Interestingly, gastrointestinal microbiome composition has emerged as a predictive biomarker of immunotherapy outcomes. This review seeks to assess the effect of microbiota-modulatory interventions on the …
·pubmed.ncbi.nlm.nih.gov·
The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients - PubMed
Exposure to prescribed medication in early life and impacts on gut microbiota and disease development - PubMed
Exposure to prescribed medication in early life and impacts on gut microbiota and disease development - PubMed
The gut microbiota during early life plays a crucial role in infant development. This microbial-host interaction is also essential for metabolism, immunity, and overall human health in later life. Early-life pharmaceutical exposure, mainly referring to exposure during pregnancy, childbirth, and infa …
·pubmed.ncbi.nlm.nih.gov·
Exposure to prescribed medication in early life and impacts on gut microbiota and disease development - PubMed
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions - PubMed
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions - PubMed
Fecal microbiota transplantation (FMT) offers a potential treatment avenue for hepatic encephalopathy (HE) by leveraging beneficial bacterial displacement to restore a balanced gut microbiome. The prevalence of HE varies with liver disease severity and comorbidities. HE pathogenesis involves ammonia …
·pubmed.ncbi.nlm.nih.gov·
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions - PubMed
Relationship among Parkinson's disease, constipation, microbes, and microbiological therapy - PubMed
Relationship among Parkinson's disease, constipation, microbes, and microbiological therapy - PubMed
This comprehensive review elucidates the complex interplay between gut microbiota and constipation in Parkinson's disease (PD), a prevalent non-motor symptom contributing significantly to patients' morbidity. A marked alteration in the gut microbiota, predominantly an increase in the abundance of …
·pubmed.ncbi.nlm.nih.gov·
Relationship among Parkinson's disease, constipation, microbes, and microbiological therapy - PubMed
[A Case of Clostridium difficile Enteritis with Ileostomy for Rectal Cancer Surgery] - PubMed
[A Case of Clostridium difficile Enteritis with Ileostomy for Rectal Cancer Surgery] - PubMed
A 74-year-old male presenting with bloody stools was diagnosed with advanced rectal cancer. He underwent robot- assisted low anterior resection and temporary ileostomy. Cefmetazole(CMZ)was administered during surgery and on postoperative day(POD)1. His postoperative course was generally good. On POD …
·pubmed.ncbi.nlm.nih.gov·
[A Case of Clostridium difficile Enteritis with Ileostomy for Rectal Cancer Surgery] - PubMed
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response - PubMed
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response - PubMed
Although ridinilazole did not meet superiority in SCR, ridinilazole greatly reduced rCDI and preserved microbiome diversity and SBAs compared with vancomycin. These findings suggest that treatment of CDI with ridinilazole results in an earlier recovery of gut microbiome health. Clinical Trials Regis …
·pubmed.ncbi.nlm.nih.gov·
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response - PubMed
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7 - PubMed
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7 - PubMed
The G protein-coupled receptors of the Frizzled (FZD) family, in particular FZD1,2,7, are receptors that are exploited by Clostridioides difficile toxin B (TcdB), the major virulence factor responsible for pathogenesis associated with Clostridioides difficile infection. We employ a live-c …
·pubmed.ncbi.nlm.nih.gov·
Structural and functional insight into the interaction of Clostridioides difficile toxin B and FZD7 - PubMed
Epidemiology of Clostridioides difficile infection at a tertiary care facility in Saudi Arabia: Results of prospective surveillance - PubMed
Epidemiology of Clostridioides difficile infection at a tertiary care facility in Saudi Arabia: Results of prospective surveillance - PubMed
In our hospital, HO-CDI incidence rate is lower than that in high-income countries. National multicenter surveillance is needed to evaluate the actual burden of CDI in Saudi Arabia.
·pubmed.ncbi.nlm.nih.gov·
Epidemiology of Clostridioides difficile infection at a tertiary care facility in Saudi Arabia: Results of prospective surveillance - PubMed
A new weapon against C. diff bacteria
A new weapon against C. diff bacteria
In a phase-one human clinical trial, a US pharmacist researcher has shown that a newer generation tetracycline antibiotic could help combat Clostridioides difficile (C. diff) bacteria.
·news.google.com·
A new weapon against C. diff bacteria
Faecal Microbiota Transplantation Alleviates Ferroptosis after Ischaemic Stroke - PubMed
Faecal Microbiota Transplantation Alleviates Ferroptosis after Ischaemic Stroke - PubMed
Ischaemic stroke can induce changes in the abundance of gut microbiota constituents, and the outcome of stroke may also be influenced by the gut microbiota. This study aimed to determine whether gut microbiota transplantation could rescue changes in the gut microbiota and reduce ferroptosis after st …
·pubmed.ncbi.nlm.nih.gov·
Faecal Microbiota Transplantation Alleviates Ferroptosis after Ischaemic Stroke - PubMed
Impact of oral vancomycin treatment duration on rate of Clostridioides difficile recurrence in patients requiring concurrent systemic antibiotics - PubMed
Impact of oral vancomycin treatment duration on rate of Clostridioides difficile recurrence in patients requiring concurrent systemic antibiotics - PubMed
Oral vancomycin prescribing relative to the systemic antibiotic end date may affect CDI recurrence to a greater extent than total vancomycin duration alone. Further studies are needed to confirm these findings.
·pubmed.ncbi.nlm.nih.gov·
Impact of oral vancomycin treatment duration on rate of Clostridioides difficile recurrence in patients requiring concurrent systemic antibiotics - PubMed
Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in Clostridioides difficile - PubMed
Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in Clostridioides difficile - PubMed
The gut microbiome engenders colonization resistance against the diarrheal pathogen Clostridioides difficile, but the molecular basis of this colonization resistance is incompletely understood. A prominent class of gut microbiome-produced metabolites important for colonization resistance agai …
·pubmed.ncbi.nlm.nih.gov·
Exogenous butyrate inhibits butyrogenic metabolism and alters virulence phenotypes in Clostridioides difficile - PubMed
Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology - PubMed
Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology - PubMed
Clostridioides difficile (C. difficile), a gram-positive anaerobic and spore-forming bacterium, is the leading cause of nosocomial antibiotic-associated diarrhea in adults which is characterized by high levels of recurrence and mortality. Surface (S)-layer Protein A (SlpA), the most ab …
·pubmed.ncbi.nlm.nih.gov·
Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology - PubMed
The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies - PubMed
The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies - PubMed
Major depressive disorder (MDD) is a common neuropsychiatric challenge that primarily targets young females. MDD as a global disorder has a multifactorial etiology related to the environment and genetic background. A balanced gut microbiota is one of the most important environmental factors involved …
·pubmed.ncbi.nlm.nih.gov·
The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies - PubMed
Gut-targeted therapies for type 2 diabetes mellitus: A review - PubMed
Gut-targeted therapies for type 2 diabetes mellitus: A review - PubMed
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia and insulin resistance. The global prevalence of T2DM has reached epidemic proportions, affecting approximately 463 million adults worldwide in 2019. Current treatments for T2DM include lifestyle modificat …
·pubmed.ncbi.nlm.nih.gov·
Gut-targeted therapies for type 2 diabetes mellitus: A review - PubMed
Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China - PubMed
Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China - PubMed
C. difficile isolates from children with reduced susceptibility to metronidazole and vancomycin are emerging in pediatric CDI in China. The lack of pCD-METRO plasmid and vanA/B associated with reduced antibiotic susceptibility suggests there are additional mechanisms of resistance.
·pubmed.ncbi.nlm.nih.gov·
Antimicrobial Resistance of Clostridioides difficile in Children from a Tertiary Pediatric Hospital in Shanghai, China - PubMed